New Nanos poll reveals people in Canada are more stressed in the era of COVID-19
OTTAWA, May 6, 2020 /CNW/ - A Nanos Research poll, conducted on behalf of the Mental Health Commission of Canada (MHCC), has found that many people in Canada have seen their stress levels double since the onset of COVID-19.
The survey of 1,049 Canadian residents conducted between April 25 and 27 sheds new light on the way people are describing their mental health during COVID-19, as well as what they are doing to improve it.
The number of participants who reported feeling stressed regularly or all the time has more than doubled since the onset of COVID-19, with fears over physical well-being and personal finances cited as the primary reasons. They are also aware of a decline in their mental health, with nearly 40 per cent reporting that their mental health is worse or somewhat worse than before the outbreak. But, despite their self-awareness, more than three in four people report that, over the last month, they have almost never or never sought mental health information online.
"The 'I'm fine' theme of this year's Mental Health Week captures the key message of this poll," said Louise Bradley, president and CEO of the MHCC.
"When we say we are 'fine,' we may not always mean it. I hope this survey reminds everyone that it's normal to feel stressed, anxious, or preoccupied during this outbreak. There is no shame in admitting as much, and there is certainly no shame in taking advantage of all the resources at your disposal to help you feel better."
Fortunately, more online mental health resources than ever are available right now, and the list is growing. The MHCC's own COVID-19 Resource Hub includes curated tips, guides, and other tools to help improve mental health during the outbreak. The federal government has also recently launched its Wellness Together Canada portal to provide mental health resources and connect people with the support they need.
"We must not only fight the virus. We've also got to fight the stigma that is likely preventing people from feeling comfortable seeking help and support," said Bradley. "The more we invest in our wellness now, the better off we will be on the other side of COVID-19."
MEDTRONIC EXPANDS DIABETES SUPPORT PROGRAMS TO HELP CUSTOMERS LOSINGINSURANCE COVERAGE DUE TO JOB LOSS AS A RESULT OF COVID-19
Medtronic Assurance Program Expands to Provide Access to Glucose Sensors and Insulin Pump Supplies at No Cost to Eligible Canadian Customers
BRAMPTON, Ontario – May 06, 2020 – Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced an expansion of the Medtronic Assurance program with a new option to support current Canadian diabetes customers who have lost their private health insurance coverage due to COVID-19related job loss. Now, eligible customers can receive a 3-month supply of infusion sets, reservoirs and/or glucose sensors at no cost.
This new addition to the Medtronic Assurance program builds on the company’s holistic approach to ensuring that customers have continued access to diabetes technology and supplies. The Medtronic Assurance program has multiple options for customers in need that include flexible payment plans and payment deferrals for those who have experienced job loss.
“These are challenging times and the COVID-19 pandemic has had a significant impact in many ways on individuals and their families. Medtronic understands our products play an important role in the day-to-day management of diabetes. We have mobilized our teams to provide remote support, increased our online education resources, and introduced financial support options for people dealing with hardships,” said Laura Cameron, senior director of the Medtronic Diabetes and Consumer Care group in Canada. “We want our customers to know that we are here for them.”
Current customers who would like to learn more about the new Medtronic Assurance program and assess their eligibility can visit www.medtronicdiabetes.ca/covid19 or call Medtronic at 1-800-284.4416 and select Option 4 (Monday – Friday; 8:00 a.m. – 8:00 p.m. EST). Supporting documentation is required and terms and conditions apply.
Medtronic is working together with the global community to change the way people manage diabetes. The company aims to transform diabetes care by expanding access, integrating care and improving outcomes, so people living with diabetes can enjoy greater freedom and better health.
About Medtronic Canada ULC
Proudly serving Canadian healthcare for over 50 years, Medtronic Canada ULC (www.medtronic.ca), is a subsidiary of Medtronic plc, which is one of the world’s largest medical technology, services, and solutions companies — alleviating pain, restoring health, and extending life for millions of people around the world. Serving physicians, hospitals, and patients across the country, Medtronic Canada ULC is headquartered in Brampton, Ontario, with regional offices in Montreal and Vancouver, and a Medtronic Resource Centre in Surrey, BC. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties, including risks related to the impact of COVID-19 on our business, operations and production, as well as demand for our offerings, competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of medical products, government regulation and general economic conditions and other risks and uncertainties described in the Company’s periodic reports on file with the U.S. Securities and Exchange Commission including the most recent Annual Report on Form 10-K of the Company, as filed with the U.S. Securities and Exchange Commission. In some cases, you can identify these statements by forward-looking words, such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “looking ahead,” “may,” “plan,” “possible,” “potential,” “project,” “should,” “will,” and similar words or expressions, the negative or plural of such words or expressions and other comparable terminology. Actual results may differ materially from anticipated results. Medtronic does not undertake to update its forward-looking statements or any of the information contained in this press release, including to reflect future events or circumstances.
Health Tech Innovator MindBeacon Works With Province of Ontario To Help People Overcome Mental Health Impact of the COVID-19 Crisis
TORONTO, May 5, 2020 /CNW/ - Effective immediately, leading digital mental and behavioural health therapy provider BEACON®, is working with the Ontario government to support mental health needs during COVID-19. BEACON will be available free of charge to Ontarians for online therapy, as part of a broader offering of services that can be selected based on needs and preferences.
"We are doing our part to expand access to our digital services in response to this growing demand. We are proud to be an Ontario company helping Ontarians," says Sam Duboc, Chair and CEO of MindBeacon Group. "In the best of times, our BEACON digital mental health service helps overcome the barriers of stigma, affordability and accessibility. The COVID-19 pandemic has further demonstrated how vital a role this service can play in supporting our health system, our economy and our people."
It is week eight since Ontarians began physical distancing measures in the fight against COVID-19 and, in this time so far, the "new normal" is not only different from individual to individual, family to family, it's constantly changing. As Ontario embarks on careful stages of reopening the economy, change continues to be a constant for the foreseeable future. Experience following other global crises demonstrate that the mental health impact can extend far beyond the duration of the immediate crisis itself.
That is why the Ontario government today announced expansion of free mental health supports to include MindBeacon's online therapy service province wide. MindBeacon is a Toronto-based company that developed BEACON as a digital therapy platform that guides individuals through a personalized course of cognitive behavioural therapy. People complete therapy online with a registered health professional providing 1-to-1 guidance through digital messaging, to help them build coping and resiliency skills over the course of weeks.
"Even though this virus has taken a heavy toll on our everyday lives, we are doing everything we can to keep people healthy, physically and mentally," said Premier Doug Ford. "By expanding access to free virtual and online mental health supports, I want those who are struggling to know that we are here to support and help you cope with the stress, isolation and anxiety during these extraordinary times."
BEACON Facts:
Launched in 2017, BEACON is the first Internet-based Cognitive Behavioural Therapy (iCBT) service offered across Canada.
Since the start of physical distancing measures in response to COVID-19 across Canada, BEACON has seen a 15-fold increase in traffic to its services.
To-date, the service has already helped thousands struggling with depression, anxiety, insomnia and post-traumatic stress.
It is the only coast-to-coast iCBT service that has reported successful results for these conditions.
Consistent in effectiveness with face-to-face structured psychotherapy and anti-depressant medication, BEACON has demonstrated that 4 in 5 users experience improvement in symptoms.
The service is available as a reimbursable benefit through nearly all Canadian group benefits plans, offered at no cost by prominent Canadian employers, and through public sector programs for post-secondary campuses, hospitals, frontline health care workers and first responder groups.
About MindBeacon Group The MindBeacon Group of companies is dedicated to helping Canadians improve their mental well-being to live their best lives. MindBeacon provides evidence-based therapy that is affordable and easy-to-access through BEACON®, the guided digital therapy service (iCBT) which has helped thousands of Canadians struggling with depression, anxiety, insomnia and posttraumatic stress. MindBeacon provides in-person and video therapy through CBT Associates, a leading psychology clinic network. mindbeacon.com
SOURCE MindBeacon
SEIU Healthcare calls for public inquiry and criminal investigations into COVID-19 related deaths
Union is calling for three urgent investigations by Premier Ford, the Regional Police, and Ontario's Chief Coroner to keep people alive and determine accountability
RICHMOND HILL, ON, May 5, 2020 /CNW/ - SEIU Healthcare, the union that represents over 60,000 frontline healthcare workers in Ontario, is calling for public inquiries and criminal investigations into COVID-19 related deaths in long-term care to keep people alive and determine accountability.
First, we're calling on Premier Ford's government to immediately commission a public inquiry, pursuant to section 3 of the Public Inquiries Act, to investigate the deaths of residents and frontline workers at Ontario's long-term care homes.
Second, we're calling on the Toronto and Peel Regional Police to initiate investigations for criminal negligence at a number of long-term care and homecare providers involving the death of staff.
Third, we're similarly calling on the Office of the Chief Coroner to use their authorities to inquire into these deaths.
On Friday, May 1st, our union lost a long-time personal support worker (PSW) who passed away after testing positive for COVID-19. She was the third avoidable death of a PSW in as many weeks.
STATEMENT FROM SEIU HEALTHCARE PRESIDENT, SHARLEEN STEWART:
A commission is urgently required because until we have a vaccine, or at a minimum, treatment available for the entire population, we must prepare now for consecutive spikes or waves of COVID-19.
Both frontline workers and the elderly in our long-term care system are saying the same thing: keep us alive.
That's why we're calling for urgent investigations that will keep people alive and hold negligent operators responsible for the death of our healthcare heroes.
SEIU Healthcare represents more than 60,000 healthcare and community service workers across Ontario. The union's members work in hospitals, homecare, nursing and retirement homes, and community services throughout the province. www.seiuhealthcare.ca
Industry Wide StaySafe coalition consists of top tele-health, medical professionals, technology, labs and distribution companies.
(Los Angeles, California) – Operation StaySafe, today announces the launch of a coalition of industry leading companies with a mission to protect our front line workers, first responders, citizens and help jumpstart our economy by getting people back to work. Many of America’s top medical testing companies have come together to form an industry-wide coalition capable of large-scale, nationwide COVID-19 testing.
Operation StaySafe will facilitate multiple testing methods for American citizens, essential workers, and businesses to provide renewed consumer confidence and kickstart the American economy.
“This is an important moment for everyone,” says John Souza, CEO of Reliant BioMedical, Operation StaySafe’s founding member. “In order to restore the confidence of the American public and restart the economy, we must make comprehensive testing available to all citizens – first responders, employees, the elderly, those most in need.”
Operation StaySafe will work hand in hand with government and business leaders to deliver a range of medically supervised tests including: nasal swab, finger prick, saliva and others authorized by the FDA at locations ranging from at home to at work, clinics, labs and more. The StaySafe solution is compliant from end-to-end and includes some of the most reliable COVID-19 testing solutions available, a fully licensed network of medical professionals along with some of the leading telemedicine and healthcare companies ready to assist American citizens and businesses nationwide.
“We designed the StaySafe coalition to operate with an Open Business Architecture,” says Paul Kirchoff, CEO of D1Labs, another Operation StaySafe founding member. “And so we invite every medical professional, lab, clinic, hospital and business to join the effort and help us expand the ability to test as many people as possible.”
StaySafe testing solutions are capable of delivering medically supervised tests at a range of locations. COVID-19 testing is complex and therefore each StaySafe solution is highly customized in order to yield the best possible results.
About Operation StaySafe: Operation StaySafe is a coalition of industry leading companies with a mission to protect our front line workers, first responders, citizens and help jumpstart our economy by getting people back to work. We accomplish this by enabling safe and scalable testing for businesses and citizens that minimizes personal, professional and public risk, speeds knowledge of results for faster action and is administered under the advisement of board-certified professionals.
Success of new research projects crucial in containing community spread of COVID-19 in India, says Globaldata
The Department of Science and Technology - Science and Engineering Board (DST-SERB) has recently initiated several special research projects. These efforts could help contain community spread of the novel coronavirus (COVID-19) in India, says GlobalData, a leading data and analytics company.
According to GlobalData COVID-19 dashboard, as of 05 May 2020, India has 46,437 confirmed cases and the dashboard forecasts 1,61,413 confirmed cases in India in a low transmission risk scenario by 17 May 2020.
The main objectives of these projects are to develop solutions to reduce community transmission and identify novel targets with the help of metabolite biomarkers.
The first set of four projects focus on preventing the spread of COVID-19. This includes the development of viricidal coatings for inanimate surfaces used in healthcare settings; small molecular and polymeric compound-based antiviral surface coatings that can kill respiratory viruses instantly upon contact; disinfecting materials to remove any adhering viruses or bacteria; and antibody-based capture of COVID-19 and its inactivation using lipid-based in situ gel at the point of entry.
Krishna Srinivasaraghavan, Pharma Analyst at GlobalData, says: “It is important that these projects are fast-tracked and scaled-up, as application of these products will greatly help in preventing the community spread of infection through contact, especially to prevent the second-wave of COVID-19 infection.”
The second set of projects primarily focuses on identifying potential metabolite biomarkers that aid in the discovery of novel targets. Recent research led by the Dr. Krogan at Gladstone Institute, showed that 332 human proteins were discovered that interacted with COVID-19 proteins, and 67 of those proteins could be used as targets for new drugs or potential drug-repurposing.
Srinivasaraghavan concludes: “Identification of novel metabolic biomarkers for COVID-19 will help in understanding the molecular mechanisms by which the new coronavirus infects human cells. This could lead to development of novel drug candidates. Metabolite biomarkers can also be combined with genetic or other biomarkers, and clinical variables for rapid diagnosis, predict the prognosis and risks associated with COVID-19, especially in elderly and immunocompromised population.
“The initiatives by DST-SERB will add to the efforts of the Indian government in fighting COVID-19, which has implemented a systematic country-wide lockdown, traced and quarantined infected people utilizing gigantic surveillance network to control the community spread of COVID-19 to a greater extent. Moreover, India’s decision to use rapid antibody tests in COVID clusters despite WHO’s advised against it, will help understand the extent of spread of infection and to take necessary control measures.”
Potential new treatment for severe dry eye disease, RCSI research
DUBLIN, May 5, 2020 -- Scientists have discovered a potential new treatment for a disease that causes severe dry eyes and dry mouth.
The study, led by researchers at RCSI University of Medicine and Health Sciences, is published in the current edition of Scientific Reports. The work was carried out in collaboration with the Royal Victoria Eye and Ear Hospital and the Cedars-Sinai Medical Centre.
Sjögren's Syndrome causes the patient’s white blood cells to attack the body’s tear and saliva glands, causing severe dry eyes and mouth. The dry and irritated eyes significantly impact their vision, day-to-day activities and quality of life.
The researchers compared samples from the eyes of patients with the disease to samples from healthy patients. They found that those with the disease had abnormal levels of a certain molecule that controls eye inflammation.
The molecule, microRNA-744, works like a switch, turning the production of cells on and off. The researchers found that high levels of this molecule caused uncontrolled amounts of inflammation from cells that destroy the glands and damage the surface of the eye.
In a laboratory setting, the researchers were able to reduce this molecule, which in turn reduced the levels of inflammation.
“This is a first step toward a potential new treatment, and much more pre-clinical testing is needed before we can develop it into something that is ready for patients. However, our research provides the opportunity to possibly treat the root cause of the disease rather than just the symptoms,” said Dr Joan Ní Gabhann-Dromgoole, the study’s co-author and lecturer at RCSI’s School of Pharmacy and Biomolecular Sciences.
The researchers also found different levels of other microRNAs in patient cells compared to healthy controls. This could be used to help diagnose patients with Sjögren's Syndrome, for which there is currently no test.
The disease is most common between the ages of 40 and 60, with women nine times more likely to suffer from it than men. It is estimated to affect three to four percent of adults in Ireland.
The research was supported by the Health Research Board and the Royal Victoria Eye and Ear Hospital Research Foundation through the Medical Research Charities Group.
About RCSI
RCSI University of Medicine and Health Sciences is ranked number one globally for Good Health and Well-being in the Times Higher Education (THE) University Impact Rankings 2020. RCSI is among the top 250 of universities worldwide in the THE World University Rankings (2020) and its research is ranked first in Ireland for citations. It is an international not-for-profit university, with its headquarters in Dublin, focused on education and research to drive improvements in human health worldwide. RCSI has been awarded Athena Swan Bronze accreditation for positive gender practice in higher education.
Visit the RCSI MyHealth Expert Directory to find the details of our experts across a range of healthcare issues and concerns. Recognising their responsibility to share their knowledge and discoveries to empower people with information that leads them to better health, these clinicians and researchers are willing to engage with the media in their area of expertise.
Brain may be new therapeutic target to improve breathing following lung injury in COVID-19 patients
UNDER STRICT EMBARGO UNTIL 01.00 GMT 07 MAY 2020
Not for publication or broadcast before this time
The brain may be a new therapeutic target for improving breathing following lung injury in COVID-19 patients, according to study in rats
New research published today in The Journal of Physiology suggests that lung injury is not limited to the lungs. Targeting the part of the brain that controls breathing and blood flow might help patients with respiratory disorders, such as lung injury due to COVID-19, and speed the process of weaning patients from mechanical ventilators.
With respiratory infections like COVID-19 or other pulmonary infections, activation of the immune system is part of the normal, healthy response. However, in some cases the inflammatory response is so powerful that it leads to further lung damage called acute lung injury (ALI) and in its most severe form acute respiratory distress syndrome (ARDS). Typical clinical care of patients with ALI and ARDS is focused on minimizing further lung damage using specialised forms of mechanical ventilation.
This new study suggests that the injury is not limited to the lungs, but may also have a lasting impact on the central control of respiration. Thus, targeting the parts of the brain that regulate our breathing might be an important therapy for weaning patients from ventilatory support following their recovery from severe respiratory infections, ALI and ARDS. This is important to understand during the COVID-19 pandemic as these patients may experience the same difficulties transitioning to breathing on their own.
Currently, ALI and ARDS therapy focuses on the lungs to maintain gas exchange and minimize further injury. These researchers examined rats with lung injury and determined that the brain regions that control breathing are affected also. In fact, the characteristics of the pathologic breathing pattern remain even when the lungs are removed. In addition, inflammation was evident in the part of the brain that generates the breathing pattern. This indicates that the lungs are not the only factor involved in breathing disorders in lung injury.
These scientists then examined what happens in conscious lung injured rodents when they introduced non-steroidal anti-inflammatory drugs within the central nervous system. They found that this treatment reduced neural inflammation and minimized the effects of lung injury. These findings suggest that brainstem circuits play a role in the pathophysiology and potential recovery of the respiratory system following lung injury and ARDS.
Commenting on the study, first author Yee-Hsee Hsieh said:
“Clinical treatment for respiratory illnesses typically focuses on adopting ventilatory protocols that protect the lung from further lung injury and current research focuses on repair and restoration of pulmonary tissue and function. This study suggests we also need to address the role of the central nervous system and neuro-inflammation to completely treat acute lung injury and perhaps other lung diseases like COVID-19.”
The Journal of Physiology publishes advances in physiology which increase our understanding of how our bodies function in health and disease. http://jp.physoc.org
The Physiological Society brings together over 4,000 scientists from over 60 countries. The Society promotes physiology with the public and parliament alike. It supports physiologists by organising world-class conferences and offering grants for research and also publishes the latest developments in the field in its three leading scientific journals, The Journal of Physiology, Experimental Physiology and Physiological Reports. www.physoc.org
Clearly donates 60,000 face shields and 1,000 safety glasses to Canadian healthcare workers
VANCOUVER, May 5, 2020 /CNW/ - During these challenging times, the team at Clearly has been humbled and inspired by the efforts of healthcare heroes and frontline workers across the country, who have made sacrifices and put their own wellbeing at risk in order to take care of others and fight the spread of COVID-19.
After learning of the shortage of personal protective equipment within hospitals and other healthcare facilities, the online eyewear brand devised a strategy to donate protective eyewear to vulnerable frontline workers across the country.
As a first step, on April 2 the Vancouver-based company provided an emergency donation of 1,052 safety glasses to the Vancouver Coastal Health network, for workers to use as a temporary alternative to face shields so they are protected while carrying out their vital roles.
Clearly has also been working with its suppliers and manufacturers to ramp up the production of personal protective equipment. So far, the organization has produced and donated an additional 60,000 face shields to the Canadian Federal Government, which will be distributed to facilities across the country through Public Health Canada, based on need.
CEO Arnaud Bussieres says: "We believe it is our duty to utilize our resources and network to support Canadian frontline workers during this crucial time. Speaking on behalf of myself and the Clearly team, we are incredibly appreciative of the efforts of those who are fighting the virus in our communities each day."
In a letter to Mr. Bussieres, Tina Namiesniowski, President of the Public Health Agency of Canada, says: "On behalf of all Canadians, I am writing to express our sincere appreciation for your company's donation to aid Canada's response to the COVID-19 pandemic. The 60,000 face shields you donated have been essential for keeping our frontline healthcare workers safe during a time of global shortages. Know that your generosity made a difference in slowing the spread of COVID-19. On behalf of the Public Health Agency of Canada, and Canadians everywhere, thank you."
This strategy aligns with the company's mission, which strives to ensure everyone has access to the eyewear and eyecare they need, pursued through initiatives like Clearly's Buy One, Give One program.
"It's our mission to eradicate poor vision in the world but it's also our duty to help protect our community in times like these." Mr. Bussieres says.
Clearly will be committing to further initiatives in the future to support Canadian frontline workers in the battle against COVID-19.
About Clearly
Founded in Vancouver in 2000, Clearly's mission is to eradicate poor vision - the largest unaddressed disability - by 2050. Clearly serves this mission and its community by providing people with the most accessible and affordable optical products. Clearly was the first Canadian retailer to offer eyewear online and is now a global leader in the design, manufacturing, and distribution of glasses, sunglasses, and contact lenses.
CORA Announces Post-Acute COVID-19 Recovery and Rehabilitation Programs
Early intervention exercise and rehabilitation to help people directly and indirectly impacted by the virus
Lima, Ohio – In response to the number of Americans impacted by coronavirus, CORA Health Services, Inc. (“CORA Physical Therapy”), a top 10 national operator of outpatient physical therapy services, has invested in specialty training for CORA clinicians to be able to address the unique needs of Post-acute COVID-19 patients and also those affected by social distancing and inactivity.
“Coronavirus is affecting many Americans, whether directly through contracting the virus or indirectly through the effects from inactivity and social distancing. Recovery Programs are essential to get back to our normal work, social and recreational activities as well as prevent long term consequences,” said Jessica Heath Byerly, Director of Clinical Education.
Symptoms of COVID-19 range from mild to severe, with approximately 80% of the cases affecting the upper respiratory system. Patients that have been discharged from a hospital and are continuing their recovery at home may still have difficulty breathing, fatigue easily, and experience pain and weakness which can lead to decreased quality of life and possible long-term implications. Furthermore, research suggests survivors may be at higher risk for future heart and kidney disease or stroke.
Due to the nature of this virus, CORA clinicians have also prepared to address the needs of patients that are affected by limitations in aerobic capacity and deconditioning because of extreme inactivity. Treatment plans will focus on meeting the needs of each patient, such as strength, balance and pain management. As details of COVID-19 have emerged, the need for early intervention exercise and recovery programs has become increasingly clear to mitigate risk of associated impairments such as decreased lung function, physical function, strength and emotional well-being.
With these programs, CORA clinicians are highly-trained in specific post-COVID focus areas and able to recommend products available at our marketplace, Therapy Essentials, to enhance their experience at home or in the clinic. This includes access to products such as pulse oximetry to monitor oxygen saturation rates and pedal exercisers to improve endurance and aerobic capacity. CORA’s licensed experts can discuss the best care pathway for patients based on their impairments and functional capacity.
CORA staff continues to take every necessary precaution, per CDC guidelines, to ensure patients have a place to engage in safe, effective physical activities in clinic or at home for relief from acute or chronic pain. Heath Byerly continued, “Having these different options for treatment, especially for post-COVID patients that are no longer contagious, allows our clinicians to ensure the best treatment based on a patients abilities and needs. We believe that this an important service that we can provide to our communities and prevent any long term implications that may occur.”
View a comprehensive enhanced precautions guide detailing the actions CORA staff is taking in every clinic to mitigate the spread of COVID-19.
About CORA
CORA Health Services, Inc./CORA Physical Therapy (www.coraphysicaltherapy.com) is an outpatient rehabilitation company that uses proven clinical practices and cost effective treatment protocols to return patients to their jobs and lifestyles as soon as possible. Their clinics offer a complete range of treatment, including outpatient physical therapy and general rehabilitation, worker’s compensation therapy, sports and auto injury rehabilitation, and rehabilitation for seniors. CORA operates more than 210 clinics in nine states: Florida, Georgia, Illinois, Kentucky, Missouri, North Carolina, South Carolina, Tennessee and Virginia, including specialty clinics under the Body Gears brand.
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
